Depression and death anxiety among patients undergoing hemodialysis during the COVID-19 pandemic in Palestine: a cross sectional study.

Depression and death anxiety among patients undergoing hemodialysis during the COVID-19 pandemic in Palestine: a cross sectional study.

Publication date: Jun 27, 2023

Hemodialysis patients are vulnerable to serious complications such as prolonged hospital stay and psychosocial issues like depression and death anxiety. Studies on psychosocial factors on end-stage renal disease patients’ outcomes during COVID-19 pandemic are limited. We aimed to determine the prevalence of depression and death anxiety among Palestinian hemodialysis patients and the evaluate the relationship between their sociodemographic and clinical characteristics during COVID-19 Pandemic. A cross-sectional study was conducted using a convenience sampling technique. We recruited 308 hemodialysis patients from five hemodialysis units located in government hospitals in Palestine. Beck Depression Inventory and the Templers Death Anxiety Scale were used to collect data, which were then analyzed using SPSS version 20. Descriptive statistics (frequencies and means), t-test, ANOVA and multiple linear regression models were used for data analysis. Nearly 66. 2% of the sample had depression symptoms, 61. 4% met the diagnostic threshold for depression, and 69. 8% had death anxiety. Furthermore, the multivariate analysis revealed that having a female identity, residing in a city or refugee camp, and patients who reported not experiencing depression had a significant relationship with death anxiety, while having a higher educational level than 12 years, having one or more chronic co-morbidities, and patients who reported experiencing death anxiety had a significant correlation with depression. Patients receiving hemodialysis frequently experience depression and death anxiety. These patients should receive a psychiatric evaluation in the early stages of their illness so that timely and appropriate psychological interventions can be given in hemodialysis facilities in Palestine during and after future pandemics.

Open Access PDF

Concepts Keywords
12years COVID-19
Hemodialysis death anxiety
Palestine depression
Psychosocial hemodialysis


Type Source Name
disease MESH death
disease MESH COVID-19 pandemic
disease MESH complications
disease MESH end-stage renal disease
disease VO ANOVA
drug DRUGBANK Methionine
drug DRUGBANK Cyclic Adenosine Monophosphate
disease MESH educational level
disease MESH morbidities
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease VO organization
disease MESH emergency
disease MESH infections
disease VO effective
disease IDO history
disease MESH cancer
disease MESH liver failure
disease MESH pulmonary embolism
disease MESH anemia
drug DRUGBANK Phosphate ion
disease MESH malnutrition
disease MESH bleeding
disease MESH mental illness
disease MESH chronic diseases
disease VO population
disease MESH Chronic Kidney Disease
drug DRUGBANK Etoperidone
disease MESH marital status
disease VO time
disease IDO intervention
disease MESH suicidal ideation
disease MESH insomnia
disease MESH coronavirus infection

Original Article

(Visited 1 times, 1 visits today)